Benitec Biopharma Inc.
For the period ended Jun 30, 2025. Filed Sep 22, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Sep 22, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
Our corporate headquarters and our research and development facility is located in Hayward, California, and consists of approximately 7,295 square feet of leased office space under a lease that expires in December 2027.
We also entered into a new lease in Los Angeles, California, for office space which has an initial expiration date in July 2026.
Management believes that these facilities are suitable and adequate to meet our anticipated needs.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.